quarterly ceo report, page-5

Yes a good report- all going to plan... Surely the market will see this as positive. Looking beyond current earnings to see the much bigger picture being that these products are leading edge.

Lab results replicated in others Coy's is a very big step IMO. As in the biotech world Lab results can differ greatly. This confirms the biotech is a winner... the comments noted by another Coy in time savings is HUGE.

Huge interest from so many sectors of the medical field- all looks up.

Bangs should have a few sales to add to the quarterly cashflow... Mercks have not had enough time yet are marketing strongly.

A few more ANNs about more signings b4 end of year will move this stock at LAST... Been around the 30Mil MC mark for a long time, surely Mr Market can now see that this Coy will make far more than 2 Mil pa. Yet we still need some guidence from the 2 Coys marketing the products.

Reaction tomorrow should be UP- but I given up guessing ever since Mercks ANN made the SP go down... Huge score on the board and Mr Market downgrades. What they need to see- BLOOD- Lol.

Yes some product sales guidence will be nice to see a real rerating and not our guessimations. Yet for my money they will make far more than 2 Mil. As SP prices the company at making in the future.

Cheers jay